The Department of Pharmacology and Toxicology awards PhD graduate students financial support through the Allen Barnett Graduate Student Fellowship.
The fellowship supports graduate students with a broad range of research and networking opportunities.
Students can apply for an award up to $2000.
The award is available to UB PhD students doing their dissertation research in Pharmacology and Toxicology laboratories.
Top priority is given to students enrolled in the PhD program in Pharmacology.
Applications are due October 31 each year.
We'll notify you within 1-2 weeks of your application if you are selected as a recipient of the Barnett fellowship.
Allen Barnett, PhD, is a drug development executive who earned his doctorate in pharmacology from the University at Buffalo in 1965. Barnett is president emeritus of Kinex, a pharmaceutical company focused on next-generation therapies for cancer and immunomodulatory diseases. During his tenure at Schering-Plough, he brought several drugs to the marketplace. He also led the effort that resulted in the discovery of Claritin, a non-sedating antihistamine that became the fifth-leading drug in the world, based on sales.